PharmaIN and Shionogi Announce Collaboration and $17M Securities
Purchase Agreements, click here for more information!


PharmaIN is a Product Development Biopharma company leveraging internal proprietary platforms for Active Pharmaceutical Ingredient (API) enhancement and delivery to enable superior products for known targets.

Protected Graft Copolymer (PGCTM) Technology: The Next Generation of PEG-based Drug Delivery.

Protective chains (e.g. 5kDa PEG)


Spacer for the drug

Our proprietary drug delivery technology for both therapeutic and imaging agents has been proven to:

Increase efficacy

Reduce toxicity

Extend circulating half-life

Enable targeted tissue accumulation

Preserve molecular structure and function